Professional medical society
Appears in 1 story · Last updated Nov 15, 2026
Host of ObesityWeek 2026, where the data were presented
Seventy-four percent of people who took Viking Therapeutics' experimental obesity drug for 13 weeks dropped at least one body mass index class. Among those on placebo, 15% did.
Updated 3 hours ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?